Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study-Reference-Cited by-同舟云学术

Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study

Published:2016-06 Issue:6 Volume:6 Page:e011454
ISSN:2044-6055
Container-title:BMJ Open
language:en
Short-container-title:BMJ Open

Author:

Nagasaka Takeshi^ORCID,Mishima Hideyuki,Sawaki Akira,Shimokawa Mototsugu,Inukai Michio,Shinozaki Katsunori,Tanioka Hiroaki,Nasu Junichiro,Nishina Tomohiro,Hazama Shoichi,Okajima Masazumi,Yamaguchi Yoshiyuki

Publisher

BMJ

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rosmarinic Acid Potentiates Cytotoxicity of Cisplatin against Colorectal Cancer Cells by Enhancing Apoptotic and Ferroptosis;Life;2024-08-15

2. Gallium complex K6 inhibits colorectal cancer by increasing ROS levels to induce DNA damage and enhance phosphatase and tensin homolog activity;MedComm;2024-07-24

3. The Number of Intraoperative Intestinal Venous Circulating Tumor Cells Is a Prognostic Factor for Colorectal Cancer Patients;Evidence-Based Complementary and Alternative Medicine;2022-09-23

4. Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed study;European Journal of Cancer;2022-07

5. Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials Group;Clinical Colorectal Cancer;2021-09